Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 81 transactions totaling $40.2M, demonstrating a bullish sentiment with $24.0M in net insider flow. The most recent transaction on Feb 3, 2026 involved a sale of 323 shares valued at $589.
IPSC Insider Activity Summary
Who Is Buying IPSC Stock?
No significant insider buying has been recorded for IPSC in the recent period.
Who Is Selling IPSC Stock?
No significant insider selling has been recorded for IPSC in the recent period.
Is Century Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IPSC is bullish with an Insider Alignment Score of 80/100 and a net flow of $24.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IPSC Frequently Asked Questions
Understanding IPSC Insider Activity
Insider trading at Century Therapeutics, Inc. (IPSC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading IPSC stock, having executed 81 transactions in the past 90 days. The most active insider is Eli Casdin (Executive), who has made 2 transactions totaling $15.0M.
Related Tools
Track Century Therapeutics, Inc. Insider Activity
Get notified when executives and directors at IPSC file new Form 4 transactions